T&R Biofab (246710) Financial Statements

OverviewFinancialsChecksFilings

In fiscal year 2025, T&R Biofab (246710) reported revenue of 27.0 billion KRW.

Income Statement

YearRevenueOp ProfitNet IncomeSource
202527.0 billion KRW-9.1 billion KRW-34.9 billion KRW[source]
20244.9 billion KRW-13.3 billion KRW-7.7 billion KRW[source]
20235.2 billion KRW-12.7 billion KRW-13.4 billion KRW[source]

Balance Sheet

YearTotal AssetsTotal LiabilitiesTotal EquitySource
202572.0 billion KRW32.3 billion KRW39.7 billion KRW[source]
202475.5 billion KRW54.6 billion KRW20.9 billion KRW[source]
202399.8 billion KRW68.6 billion KRW31.2 billion KRW[source]
Financials & Filings: DART (traceable by receipt number) · Prices: Financial Services Commission · Data Sources · Last checked: 2026-08-29 · About · Delisting market cap threshold: KOSPI 5B KRW / KOSDAQ 4B KRW (per listing rules) · This page provides factual information, not investment advice